[EN] FURAN DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS<br/>[FR] DERIVES DE FURANE UTILISES COMME ANTAGONISTES DU RECEPTEUR EP4
申请人:PHARMAGENE LAB LTD
公开号:WO2005037812A1
公开(公告)日:2005-04-28
A compound of formula: (I); or a salt, solvate and chemically protected form thereof, wherein one of R2 and R5 is: (i) H or an optionally substituted C1-4 alkyl group; or (ii)an optionally substituted C5-7 aryl; and the other of R2 and R5 is the other group; m and n can be 0 or 1, and m + n = 1 or 2 RN is H or optionally substituted C1-4 alkyl R3 is either: (i) carboxy; (ii) a group of formula: (II); (iii) a group of formula: (III); wherein R is optionally substituted C1-7 alkyl, C5-20 aryl, or NRN3RN4 , where RN3 and RN4 are independently selected from optionally substituted C1-4 alkyl; or (iv) tetrazol-5-yl.
一种化合物的化学式为:(I); 或其盐、溶剂合物和化学保护形式,其中R2和R5中的一个是:(i) H或可选择地取代的C1-4烷基;或(ii)可选择地取代的C5-7芳基;另一个是另一种基团;m和n可以为0或1,且m + n = 1或2;RN为H或可选择地取代的C1-4烷基;R3可以是:(i)羧基;(ii)化学式为(II)的基团;(iii)化学式为(III)的基团;其中R可选择地取代的C1-7烷基、C5-20芳基或NRN3RN4,其中RN3和RN4分别选择自可选择地取代的C1-4烷基;或(iv)噻唑-5-基。